title: Effects of exogenous steroids on androgen receptors in fetal guinea pig brain.
abstract: We treated pregnant guinea pigs on Day 50 of gestation with 10 mg testosterone propionate (TP), obtaining fetuses 2, 4, 8, or 18 h later as well as after 5 days of treatment. In a second group of pregnant guinea pigs, dihydrotestosterone propionate (DHTP), estradiol benzoate (E2B), progesterone (P), or cortisol was given 2 h before obtaining fetuses. Although TP treatment elevated fetal serum T (p less than 0.05), brain cytosolic androgen receptor (ARc) content was unchanged in fetuses of either sex. In female fetuses, nuclear androgen receptors (ARn) increased 10-fold in medial-basal hypothalamus (MBH) and preoptic area (POA) at 2 and 4 h (respectively) after treatment, while fetal male ARn content was unchanged. Maternal injection of other steroids (E2B, P, or cortisol, but not DHTP) significantly increased these hormones in the fetus 2 h later (p less than 0.05). Only androgens affected fetal androgen receptor (AR) content. While TP increased ARn in female MBH, DHTP decreased ARc in fetal anterior pituitary of both sexes. In this latter case, a metabolite of DHT may mediate the effects. We conclude that T crosses the guinea pig placenta and activates ARn in POA and MBH of female fetuses; male ARn appear to be maximally occupied by endogenous T. Steroids of other classes do not induce AR responses in fetal guinea pig brain. These AR changes may represent an initial cellular mechanism in brain sexual differentiation.
authors.affiliation: Department of Physiology, School of Medicine, Oregon Health Sciences University, Portland 97201-3098.
authors.forename: K T
authors.initials: KT
authors.lastname: Toyooka
authors.forename: P B
authors.initials: PB
authors.lastname: Connolly
authors.forename: J A
authors.initials: JA
authors.lastname: Resko
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D013196:Dihydrotestosterone / Q000031:analogs & derivatives / Q000494:pharmacology; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D005333:Fetus / Q000187:drug effects* / Q000378:metabolism; D006168:Guinea Pigs; D007033:Hypothalamus, Middle / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011301:Preoptic Area / Q000187:drug effects / Q000378:metabolism; D011944:Receptors, Androgen / Q000187:drug effects* / Q000378:metabolism; D012733:Sex Differentiation / Q000187:drug effects / Q000502:physiology; D013256:Steroids / Q000494:pharmacology*; D013739:Testosterone / Q000494:pharmacology
chemical_list: D011944:Receptors, Androgen; D013256:Steroids; D013196:Dihydrotestosterone; D013739:Testosterone; D004958:Estradiol; C030445:dihydrotestosterone propionate; C010452:estradiol-17 beta-benzoate